Suchergebnisse - "Talamonti, Marina"

PubPharm (9)

1

Efficacy and Safety of Secukinumab in Elderly Patients with Moderate to Severe Plaque-Type Psoriasis : Post-Hoc Analysis of the SUPREME Study

enthalten in: Clinical, cosmetic and investigational dermatology | 2023

von Talamonti, M. | Russo, F. | Malara, G. | +23

2

Secukinumab for the treatment of palmoplantar psoriasis : a 2-year, multicenter, real-life observational study

enthalten in: Expert opinion on biological therapy | 2022

von Galluzzo, M. | Talamonti, M. | Atzori, L. | +12

3

Secukinumab Improves Patient Perception of Anxiety and Depression in Patients with Moderate to Severe Psoriasis : A Post hoc Analysis of the SUPREME Study

enthalten in: Acta dermato-venereologica | 2021

von Talamonti, M. | Malara, G. | Natalini, Y. | +22

4

HLA-Cw6 and other HLA-C alleles, as well as MICB-DT, DDX58, and TYK2 genetic variants associate with optimal response to anti-IL-17A treatment in patients with psoriasis

enthalten in: Expert opinion on biological therapy | 2021

von Morelli, M. | Galluzzo, M. | Madonna, S. | +9

5

Impact of secukinumab on patient-reported outcomes in moderate to severe plaque psoriasis : a review of clinical studies

enthalten in: Expert opinion on biological therapy | 2021

von Galluzzo, M. | Talamonti, M. | Manfreda, V. | +5

6

Status of a real-life cohort of patients with moderate-to-severe plaque psoriasis treated with secukinumab and considerations on the use of biological agents in the Covid-19 era

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | Tofani, L. | Bianchi, L. | +1

7

In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis

enthalten in: Expert opinion on biological therapy | 2020

von Galluzzo, M. | D'Adamio, S. | Silvaggio, D. | +3

8

Biologic therapy for acrodermatitis continua of Hallopeau : Successful treatment with secukinumab and review of the literature

enthalten in: Dermatologic therapy | 2019

von Galluzzo, M. | D'Adamio, S. | Teoli, M. | +2

9

Secukinumab in moderate-to-severe plaque psoriasis : a multi-center, retrospective, real-life study up to 52 weeks observation

enthalten in: Expert opinion on biological therapy | 2018

von Galluzzo, M. | Talamonti, M. | De Simone, C. | +7

1
[1]